Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.
CEO
Chairman Of The Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Avanza Pension | 7,22 | 7,22 | 2019-09-30 |
| Thord Wilkne | 2,53 | 2,53 | 2019-09-30 |
| Vidarstiftelsen | 2,36 | 2,36 | 2019-09-30 |
| Ramin Hossein Khatiri | 2,18 | 2,18 | 2019-09-30 |
| Arne Ryberg | 1,96 | 1,96 | 2019-09-30 |
| Nordnet Pensionsförsäkring | 1,94 | 1,94 | 2019-09-30 |
| Dan Markusson | 1,50 | 1,50 | 2019-08-19 |
| Kerstin Uvnäs Moberg | 1,47 | 1,47 | 2019-09-30 |
| Henrik Hahn | 1,39 | 1,39 | 2019-09-30 |
| Humard AB | 1,32 | 1,32 | 2019-09-30 |
2019-11-08 Delårsrapport 2019-Q3
2020-02-27 Bokslutskommuniké 2019